PTC Therapeutics, Inc. (PTCT) Earnings History
Net Loss15 years of earnings data (2011–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
PTC Therapeutics, Inc. (PTCT) Earnings Overview
As of June 22, 2026, PTC Therapeutics, Inc. (PTCT) reported trailing twelve-month net income of -$187M, reflecting +264.5% year-over-year growth. The company earned $-2.26 per diluted share over the past four quarters, with a net profit margin of 39.4%.
Looking at the long-term picture, PTCT's historical earnings data spans multiple years. The company achieved its highest annual net income of $683M in fiscal 2025, representing a new all-time high.
PTC Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SRPT ($65M net income, -32.5% margin), BMRN ($269M net income, 10.8% margin), RARE (-$609M net income, -85.4% margin), PTCT has outperformed on profitability metrics. Compare PTCT vs SRPT →
PTCT Earnings vs Peers
Earnings metrics vs comparable public companies
PTCT Historical Earnings Data (2011–2025)
15 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $683M | +287.9% | $857M | $7.78 | 39.4% | 49.5% |
| 2024 | -$363M | +42.0% | -$303M | $-4.73 | -45.0% | -37.5% |
| 2023 | -$627M | -12.1% | -$440M | $-8.37 | -66.8% | -46.9% |
| 2022 | -$559M | -6.7% | -$447M | $-7.79 | -80.0% | -64.0% |
| 2021 | -$524M | -19.6% | -$374M | $-7.43 | -97.3% | -69.5% |
| 2020 | -$438M | -74.2% | -$432M | $-6.64 | -115.1% | -113.4% |
| 2019 | -$252M | -96.4% | -$241M | $-4.27 | -82.0% | -78.6% |
| 2018 | -$128M | -62.1% | -$116M | $-2.75 | -48.4% | -43.7% |
| 2017 | -$79M | +44.4% | -$64M | $-2.02 | -40.6% | -33.1% |
| 2016 | -$142M | +16.6% | -$132M | $-4.17 | -171.8% | -159.7% |
| 2015 | -$170M | -81.8% | -$167M | $-5.07 | -463.6% | -454.6% |
| 2014 | -$94M | -81.8% | -$99M | $-2.97 | -408.3% | -432.9% |
| 2013 | -$52M | -96.6% | -$45M | $-4.02 | -164.6% | -144.9% |
| 2012 | -$26M | -184.9% | -$27M | $-1.11 | -91.2% | -93.2% |
| 2011 | $31M | - | $31M | $0.00 | 31.2% | 30.9% |
Download Data
Export PTCT earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
15+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PTCT — Frequently Asked Questions
Quick answers to the most common questions about buying PTCT stock.
What is PTCT earnings per share (EPS)?
PTCT trailing twelve-month (TTM) diluted EPS is $-2.26, reflecting +264.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2011 to 2025 is available in the table on this page.
What is PTC Therapeutics, Inc.'s net income?
PTC Therapeutics, Inc. (PTCT) trailing twelve-month net income is $-187M as of 2025. Earnings grew +264.5% year-over-year.
Is PTCT profitable?
PTCT is not currently profitable on a TTM basis, reporting a net loss of $-187M. Net margin is +39.4%. Investors should monitor for a return to profitability.
What is PTCT's earnings growth rate?
PTCT compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2011 to 2025.
What are PTCT's profit margins?
PTC Therapeutics, Inc. net profit margin is +39.4%, operating margin is +49.5%, and gross margin is +95.9%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is N/A.
Is PTCT growing earnings?
Yes, PTCT earnings are accelerating — EPS growth of +264.5% exceeds the 5-year CAGR of N/A. TTM net income reached $-187M. Earnings momentum is strengthening.
What was PTCT's best earnings year?
PTC Therapeutics, Inc.'s highest annual net income on record is $683M, achieved in fiscal year 2025. Earnings history on this page spans 2011 to 2025 and includes all annual and quarterly figures.
What were PTCT's earnings last quarter?
PTCT's most recent reported quarter was Q1 2026. Net income was $-3M with diluted EPS of $-0.03. For a full breakdown of all quarters, see the quarterly earnings table on this page.